EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection

Benoît Allignet iD, Paul Pou, Floriane Izarn iD, Isabelle Ray-Coquard iD, Jean-Yves Blay iD, Armelle Dufresne iD, Mehdi Brahmi iD, Amine Bouhamama iD, Pierre Meeus iD, Gualter Vaz iD, Francois Gouin iD, Alexandra Meurgey und 4 weitere

The Oncologist · 2023

DOI: 10.1093/oncolo/oyad076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2023. Verfasst von Benoît Allignet und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Centre Léon Bérard, Lyon, France. Hauptthemen laut MEDLINE: Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The objective of this study was to evaluate the efficacy and safety of adjuvant radiotherapy (aRT) in patients with soft-tissue sarcoma (STS) re-excised after unplanned tumor resection (UPR). Materials and Methods From 2000 to 2015, we retrospectively evaluated patients with STS of limb or trunk who underwent post-UPR re-excision in our expert center and received or not aRT.

Results

Median follow-up was 121 months (IQR 94-165). Among the 145 patients, 37 were not treated with aRT (no-RT) and 108 received aRT with a median radiation dose of 50 Gy (IQR 50-60). At 10 years, patients in the aRT and no-RT groups showed a cumulative incidence of local failure (10y-LF) of 14.7% and 37.7%, and a local recurrence-free survival (10y-LRFS) of 61.3% and 45.8%, respectively. Multivariate analysis identified aRT and age ≥70 years as independent predictors of both LF and LRFS, while grade 3 and deep-seated tumor were independent predictors of LRFS. In overall population, 10-year distant metastasis-free survival (10y-DMFS) and overall survival (10y-OS) were 63.7% and 69.4%. In multivariate analyses, age ≥70 years, grade 3, and deep-seated lesion were associated with shorter DMFS and OS. Acute severe adverse events were not significantly increased in aRT group (14.8% vs. 18.1%, P = .85) but dramatically increased if radiation dose exceeded 50 Gy (risk ratio 2.96 compared to ≤50 Gy, P = .04).

Conclusion

In STS patients re-excised after UPR, 50 Gy aRT was safe and associated with reduced LF and longer LRFS. It seems to be beneficial even in absence of residual disease or in absence of initial adverse prognostic factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaSoft Tissue NeoplasmsHumansAgedRadiotherapy, AdjuvantRetrospective StudiesExtremitiesReoperationNeoplasm Recurrence, Local

Stichwörter der Autor:innen

adjuvant radiotherapyre-excisionsoft-tissue sarcomaunplanned resection

Autor:innen und Institutionen

  • Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
  • Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1294, 69621, Lyon, France.
  • Department of Radiation Oncology, Ramsay Générale de Santé, Centre de Radiothérapie Haute Savoie Nord, Contamine Sur Arve, France.
  • Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Department of Radiology, Centre Léon Bérard, Lyon, France.
  • Department of Surgical Oncology, Centre Léon Bérard, Lyon, France.

ORCID-Profile: Benoît Allignet, Floriane Izarn, Isabelle Ray-Coquard, Jean-Yves Blay, Armelle Dufresne, Mehdi Brahmi, Amine Bouhamama, Pierre Meeus, Gualter Vaz, Francois Gouin, Marie Karanian, Coralie Moncharmont, Waisse Waissi, Marie-Pierre Sunyach

Zitieren

APA

Allignet, B., Pou, P., Izarn, F., Ray-Coquard, I., Blay, J. Y., Dufresne, A., Brahmi, M., Bouhamama, A., Meeus, P., Vaz, G., Gouin, F., Meurgey, A., Karanian, M., Moncharmont, C., Waissi, W., & Sunyach, M. P. (2023). Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection. The Oncologist. https://doi.org/10.1093/oncolo/oyad076

Vancouver

Allignet B, Pou P, Izarn F, Ray-Coquard I, Blay JY, Dufresne A, et al. Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection. The Oncologist. 2023. doi:10.1093/oncolo/oyad076

BibTeX
@article{Allignet2023,
  author = {Allignet, Benoît and Pou, Paul and Izarn, Floriane and Ray-Coquard, Isabelle and Blay, Jean-Yves and Dufresne, Armelle and Brahmi, Mehdi and Bouhamama, Amine and Meeus, Pierre and Vaz, Gualter and Gouin, Francois and Meurgey, Alexandra and Karanian, Marie and Moncharmont, Coralie and Waissi, Waisse and Sunyach, Marie-Pierre},
  title = {Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection},
  journal = {The Oncologist},
  year = {2023},
  doi = {10.1093/oncolo/oyad076}
}
Kostenlos starten →